Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Ardelyx, Inc.

< Previous 1 2 3 Next >
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Tenapanor Approved in China for Hyperphosphatemia
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Participate in Upcoming Investor Conferences
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
From Ardelyx, Inc.
Via GlobeNewswire
Tickers ARDX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.